Itasca, Ill.— In a new policy statement published today, the American Academy of Pediatrics (AAP) recommends vaccinating all children ages 12 and older who are eligible for the federally authorized COVID-19 vaccine.
The AAP policy statement comes amid a discussion by the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention (CDC) on the Pfizer-BioNTech vaccine for adolescents 12 years and older, including a review of the data provided by clinical trials. Earlier this week, the U.S. Food and Drug Administration granted an Emergency Use Authorization for use of the vaccine in the 12- to 15-year age group. Both steps were part of a long-standing, rigorous and transparent process that leads to the development of all vaccines.
“This is truly an exciting development that allows us to protect a large population of children and help them regain their lives after a really rough year,” said AAP President Lee Savio Beers, MD, FAAP. “As a pediatrician and a parent, I have looked forward to getting my own children and patients vaccinated, and I am thrilled that those ages 12 and older can now be protected. The data continue to show that this vaccine is safe and effective. I urge all parents to call their pediatrician to learn more about how to get their children and teens vaccinated.”
Read the news release here.